JPMorgan Chase & Co. Acquires 275,423 Shares of Chemed Corporation $CHE

JPMorgan Chase & Co. boosted its holdings in shares of Chemed Corporation (NYSE:CHEFree Report) by 122.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 499,968 shares of the company’s stock after acquiring an additional 275,423 shares during the period. JPMorgan Chase & Co. owned 3.53% of Chemed worth $223,856,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Geneos Wealth Management Inc. grew its stake in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the period. R Squared Ltd bought a new position in Chemed during the second quarter worth about $239,000. Ground Swell Capital LLC acquired a new position in shares of Chemed during the 2nd quarter worth about $212,000. AlphaQuest LLC grew its position in shares of Chemed by 76.8% during the 2nd quarter. AlphaQuest LLC now owns 3,226 shares of the company’s stock worth $1,571,000 after buying an additional 1,401 shares during the period. Finally, Brighton Jones LLC bought a new stake in shares of Chemed in the 2nd quarter valued at about $224,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CHE. Royal Bank Of Canada reduced their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $555.50.

View Our Latest Analysis on CHE

Chemed Stock Up 0.7%

Shares of CHE stock opened at $475.35 on Friday. Chemed Corporation has a 12-month low of $408.42 and a 12-month high of $623.60. The firm has a fifty day moving average of $444.77 and a 200-day moving average of $443.47. The company has a market capitalization of $6.73 billion, a price-to-earnings ratio of 25.14, a P/E/G ratio of 2.30 and a beta of 0.44.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be paid a $0.60 dividend. The ex-dividend date of this dividend is Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.29% of the stock is currently owned by company insiders.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.